ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
신경유전체학(Neurogenomics) 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 14.7%로 26억 달러로 성장합니다. 예측 기간의 성장은 정신건강에 대한 개인 맞춤형 치료에 대한 관심 증가, 소비자 직접 판매 신경유전학 검사 이용 확대, 멀티오믹스 접근법 채택 확대, 정밀 신경학 구상 확대, 표적치료제 이용 확대 등에 기인하는 것으로 보입니다. 이 기간 중 예상되는 주요 동향으로는 인공지능을 활용한 유전체 분석 개발, 비침습적 진단 플랫폼의 발전, 멀티오믹스 기술의 통합, 정밀 신경학에 유전체학의 접목, 신경퇴행성 질환 모델링의 기술 혁신 등이 있습니다.
신경질환의 유병률 증가는 향후 수년간 신경유전체학 시장의 성장을 가속할 것으로 예측됩니다. 신경질환은 뇌, 척수, 신경에 영향을 미치는 병으로 근력저하, 발작, 만성통증, 인지장애 등의 증상을 유발할 수 있습니다. 이러한 유병률 증가는 식생활의 불균형, 운동 부족, 만성 스트레스, 환경독소 노출 증가 등 생활습관 관련 요인에 기인하는 바가 큽니다. 신경유전체학은 뇌 기능 및 기능 장애의 유전적 기반에 대한 인사이트를 제공함으로써 진단을 개선하고, 근본 원인을 규명하고, 표적 치료를 가능하게 함으로써 이러한 장애에 대처하는 데 중요한 역할을 하고 있습니다. 예를 들어 2023년 3월 알츠하이머병 협회(Alzheimer's Association)는 65세 이상 미국인 중 약 670만 명이 알츠하이머형 치매를 앓고 있다고 보고했습니다. 이 수치는 2060년까지 1,380만 명으로 증가할 것으로 예측됩니다. 이처럼 신경질환 유병률 증가는 신경유전체학 시장의 확대에 기여하고 있습니다.
신경유전체학 시장의 주요 기업은 희귀하고 복잡한 신경질환의 진단과 이해를 향상시키기 위해 전장유전체 시퀀싱 플랫폼과 같은 첨단 기술 개발에 주력하고 있습니다. 전장 유전체 염기서열 분석 플랫폼은 개인의 유전체 전체 DNA 염기서열을 분석하여 신경질환과 관련된 유전적 요인을 규명하는 데 도움을 주고 있습니다. 예를 들어 2023년 4월 독일에 본사를 둔 희귀질환 전문 진단 및 연구 기업 Centogene N.V.는 희귀질환 및 신경퇴행성 질환 진단을 위한 세계에서 가장 종합적인 전장유전체 염기서열 분석(WGS) 솔루션인 CentoGenome을 발표했습니다. 이 플랫폼은 특히 시퀀싱이 어려운 유전자 영역에서 고품질의 편향성 없는 시퀀싱을 위한 PCR-free 기술을 통합하고 있습니다. 정교한 바이오인포매틱스 파이프라인과 전문가 분석으로 변이체 검출을 개선하여 한 번의 검사로 거의 모든 질병을 유발하는 변이를 포착합니다. 또한 이 서비스에는 새로운 유전학적 지식이 밝혀질 경우 변종 재분류 및 확인 검사를 무료로 제공하는 평생 통합 진단 지원도 포함되어 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 신경유전체학 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 신경유전체학 시장 : 성장률 분석
세계의 신경유전체학 시장 실적 : 규모와 성장, 2019-2024
세계의 신경유전체학 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 신경유전체학 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 신경유전체학 시장 : 제공별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
차세대 시퀀싱
중합효소 연쇄 반응
마이크로어레이
소프트웨어와 서비스
세계의 신경유전체학 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
변이체 발견
조사 애플리케이션
타겟 식별
전사 인자 결합 분석
기능 연구
임상 응용
세계의 신경유전체학 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제약 및 바이오테크놀러지 기업
학술연구기관
병원 및 진단 검사실
세계의 신경유전체학 시장 : 서브 세분화, 차세대 시퀀싱(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
전게놈 배열 해석
전엑솜 시퀀싱
타겟 시퀀싱
리보핵산 배열 해석
세계의 신경유전체학 시장 : 서브 세분화, 중합효소 연쇄 반응(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
실시간 중합효소 연쇄 반응
역전사 중합효소 연쇄 반응
디지털 중합효소 연쇄 반응
세계의 신경유전체학 시장 : 서브 세분화, 마이크로어레이(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
디옥시리보핵산 마이크로어레이
리보핵산 마이크로어레이
단백질 마이크로어레이
세계의 신경유전체학 시장 : 서브 세분화, 소프트웨어와 서비스(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
데이터 분석 및 해석 소프트웨어
게놈 데이터 관리툴
커스텀 서비스
클라우드 기반 플랫폼과 리포트 툴
제7장 지역별·국가별 분석
세계의 신경유전체학 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 신경유전체학 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
신경유전체학 시장 : 경쟁 구도
신경유전체학 시장 : 기업 개요
F. Hoffmann-La Roche Limited Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Incorporated Overview, Products and Services, Strategy and Financial Analysis
Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Agilent Technologies Inc.
Illumina Inc.
Revvity Inc.
QIAGEN N.V.
Myriad Genetics Inc.
GeneDx LLC
Fulgent Genetics Inc.
Oxford Nanopore Technologies Plc
Vigil Neuroscience Inc.
PacBio
MedGenome Labs Ltd.
MGI Tech Co. Ltd.
Centogene N.V.
Variantyx Inc.
Neurogene
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
신경유전체학 시장 2029 : 새로운 기회를 제공하는 국가
신경유전체학 시장 2029 : 새로운 기회를 제공하는 부문
신경유전체학 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Neurogenomics is the study of how the genome affects the development and function of the nervous system, integrating neuroscience and genomics to better understand brain-related diseases, behavior, and cognition. Through the analysis of gene expression and genetic variations, researchers aim to uncover the underlying mechanisms of neurological disorders, advancing personalized medicine approaches in neurology.
The primary offerings in neurogenomics include next-generation sequencing (NGS), polymerase chain reaction (PCR), microarrays, and related software and services. Next-generation sequencing is a high-throughput DNA sequencing technology that enables the rapid and parallel analysis of millions of DNA fragments to determine their precise sequence. These technologies support a wide array of applications, including variant discovery, research studies, target identification, transcription factor binding analysis, functional genomics, and clinical diagnostics. Key end users include pharmaceutical and biotechnology companies, academic and research institutions, and hospitals and diagnostic laboratories.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The neurogenomics market research report is one of a series of new reports from The Business Research Company that provides neurogenomics market statistics, including neurogenomics global market size, regional shares, competitors with neurogenomics market share, detailed neurogenomics market segments, market trends and opportunities, and any further data you may need to thrive in the neurogenomics industry. The neurogenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The neurogenomics market size has grown rapidly in recent years. It will grow from $1.31 billion in 2024 to $1.50 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. Growth during the historic period can be attributed to the rising demand for genetic testing in neurological disorders, increased research on the connections between the brain, behavior, and genome, the growing prevalence of neurodegenerative diseases, increased funding for neuroscience research, and the expansion of biobanks and genomic databases.
The neurogenomics market size is expected to see rapid growth in the next few years. It will grow to $2.60 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. Growth in the forecast period can be attributed to the rising interest in personalized treatments for mental health, increased use of direct-to-consumer neurogenetic testing, growing adoption of multi-omics approaches, expansion of precision neurology initiatives, and greater use of targeted therapies. Key trends expected during this period include the development of artificial intelligence-powered genomic analytics, advancements in non-invasive diagnostic platforms, integration of multi-omics technologies, incorporation of genomics into precision neurology, and innovations in modeling neurodegenerative diseases.
The rising prevalence of neurological disorders is expected to drive the growth of the neurogenomics market in the coming years. Neurological disorders are medical conditions that impact the brain, spinal cord, or nerves and can cause symptoms such as muscle weakness, seizures, chronic pain, or cognitive impairments. This increase in prevalence is largely attributed to lifestyle-related factors, including poor dietary habits, insufficient physical activity, chronic stress, and greater exposure to environmental toxins. Neurogenomics plays a crucial role in addressing these disorders by offering insights into the genetic underpinnings of brain function and dysfunction, thereby improving diagnosis, identifying root causes, and enabling targeted treatments. For example, in March 2023, the Alzheimer's Association reported that approximately 6.7 million Americans aged 65 and older were living with Alzheimer's dementia. This figure is projected to increase to 13.8 million by 2060. Thus, the growing incidence of neurological disorders is contributing to the expansion of the neurogenomics market.
Leading companies in the neurogenomics market are focusing on developing cutting-edge technologies such as whole genome sequencing platforms to improve the diagnosis and understanding of rare and complex neurological conditions. Whole genome sequencing platforms analyze the complete DNA sequence of an individual's genome and are instrumental in identifying genetic factors linked to neurological disorders. For instance, in April 2023, Centogene N.V., a Germany-based diagnostics and research company specializing in rare diseases, introduced CentoGenome, the world's most comprehensive whole-genome sequencing (WGS) solution for diagnosing rare and neurodegenerative conditions. This platform incorporates PCR-free technology for high-quality, unbiased sequencing, particularly across difficult-to-sequence genetic regions. It improves variant detection through a sophisticated bioinformatics pipeline and expert analysis, capturing nearly all disease-causing variants in a single test. The service also includes integrated, lifelong diagnostic support, with free variant reclassification and confirmatory testing as new genetic insights emerge.
In February 2025, Tempus AI Inc., a US-based health technology company, acquired Ambry Genetics for $600 million. This acquisition was intended to enhance Tempus AI's precision medicine platform by incorporating Ambry Genetics' specialized capabilities in hereditary and clinical genetic testing. The integration broadens Tempus AI's reach across various therapeutic areas, including oncology, cardiology, rare diseases, and neurological conditions. Ambry Genetics Corporation, a US-based genetic testing company, provides neurogenomics services through a wide array of genetic testing options for neurological and neurodevelopmental disorders.
Major players in the neurogenomics market are F. Hoffmann-La Roche Limited, Thermo Fisher Scientific Incorporated, Danaher Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Myriad Genetics Inc., GeneDx LLC, Fulgent Genetics Inc., Oxford Nanopore Technologies Plc., Vigil Neuroscience Inc., PacBio, MedGenome Labs Ltd., MGI Tech Co. Ltd., Centogene N.V., Variantyx Inc., and Neurogene.
North America was the largest region in the neurogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neurogenomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the neurogenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The neurogenomics market consists of revenues earned by entities by providing services such as genomic sequencing services, bioinformatics and data analysis, research and clinical trial support, customized gene panel development, and pharmacogenomics services. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurogenomics market also includes sales of genomic sequencing kits, microarray chips, bioinformatics software, neurogenomic biomarkers, and single-cell genomics kits. Values in this market are 'factory gate' values that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Neurogenomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on neurogenomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for neurogenomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurogenomics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Offering: Next-Generation Sequencing; Polymerase Chain Reaction; Microarray; Software And Services
2) By Application: Variant Discovery; Research Applications; Target Identification; Transcription Factor Binding Analysis; Functional Studies; Clinical Applications
3) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Hospitals And Diagnostic Laboratories
2) By Polymerase Chain Reaction: Real-Time Polymerase Chain Reaction; Reverse Transcription Polymerase Chain Reaction; Digital Polymerase Chain Reaction
3) By Microarray: Deoxyribonucleic Acid Microarray; Ribonucleic Acid Microarray; Protein Microarray
4) By Software And Services: Data Analysis And Interpretation Software; Genomic Data Management Tools; Custom Services; Cloud-Based Platforms And Reporting Tools
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Neurogenomics Market Characteristics
3. Neurogenomics Market Trends And Strategies
4. Neurogenomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Neurogenomics Growth Analysis And Strategic Analysis Framework
5.1. Global Neurogenomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Neurogenomics Market Growth Rate Analysis
5.4. Global Neurogenomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Neurogenomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Neurogenomics Total Addressable Market (TAM)
6. Neurogenomics Market Segmentation
6.1. Global Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing
Polymerase Chain Reaction
Microarray
Software And Services
6.2. Global Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Variant Discovery
Research Applications
Target Identification
Transcription Factor Binding Analysis
Functional Studies
Clinical Applications
6.3. Global Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic And Research Institutes
Hospitals And Diagnostic Laboratories
6.4. Global Neurogenomics Market, Sub-Segmentation Of Next-Generation Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing
Ribonucleic Acid Sequencing
6.5. Global Neurogenomics Market, Sub-Segmentation Of Polymerase Chain Reaction, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Real-Time Polymerase Chain Reaction
Reverse Transcription Polymerase Chain Reaction
Digital Polymerase Chain Reaction
6.6. Global Neurogenomics Market, Sub-Segmentation Of Microarray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Deoxyribonucleic Acid Microarray
Ribonucleic Acid Microarray
Protein Microarray
6.7. Global Neurogenomics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Analysis And Interpretation Software
Genomic Data Management Tools
Custom Services
Cloud-Based Platforms And Reporting Tools
7. Neurogenomics Market Regional And Country Analysis
7.1. Global Neurogenomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Neurogenomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Neurogenomics Market
8.1. Asia-Pacific Neurogenomics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Neurogenomics Market
9.1. China Neurogenomics Market Overview
9.2. China Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Neurogenomics Market
10.1. India Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Neurogenomics Market
11.1. Japan Neurogenomics Market Overview
11.2. Japan Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Neurogenomics Market
12.1. Australia Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Neurogenomics Market
13.1. Indonesia Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Neurogenomics Market
14.1. South Korea Neurogenomics Market Overview
14.2. South Korea Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Neurogenomics Market
15.1. Western Europe Neurogenomics Market Overview
15.2. Western Europe Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Neurogenomics Market
16.1. UK Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Neurogenomics Market
17.1. Germany Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Neurogenomics Market
18.1. France Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Neurogenomics Market
19.1. Italy Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Neurogenomics Market
20.1. Spain Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Neurogenomics Market
21.1. Eastern Europe Neurogenomics Market Overview
21.2. Eastern Europe Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Neurogenomics Market
22.1. Russia Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Neurogenomics Market
23.1. North America Neurogenomics Market Overview
23.2. North America Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Neurogenomics Market
24.1. USA Neurogenomics Market Overview
24.2. USA Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Neurogenomics Market
25.1. Canada Neurogenomics Market Overview
25.2. Canada Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Neurogenomics Market
26.1. South America Neurogenomics Market Overview
26.2. South America Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Neurogenomics Market
27.1. Brazil Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Neurogenomics Market
28.1. Middle East Neurogenomics Market Overview
28.2. Middle East Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Neurogenomics Market
29.1. Africa Neurogenomics Market Overview
29.2. Africa Neurogenomics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Neurogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Neurogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Neurogenomics Market Competitive Landscape And Company Profiles
30.1. Neurogenomics Market Competitive Landscape
30.2. Neurogenomics Market Company Profiles
30.2.1. F. Hoffmann-La Roche Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Thermo Fisher Scientific Incorporated Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
31. Neurogenomics Market Other Major And Innovative Companies
31.1. Agilent Technologies Inc.
31.2. Illumina Inc.
31.3. Revvity Inc.
31.4. QIAGEN N.V.
31.5. Myriad Genetics Inc.
31.6. GeneDx LLC
31.7. Fulgent Genetics Inc.
31.8. Oxford Nanopore Technologies Plc
31.9. Vigil Neuroscience Inc.
31.10. PacBio
31.11. MedGenome Labs Ltd.
31.12. MGI Tech Co. Ltd.
31.13. Centogene N.V.
31.14. Variantyx Inc.
31.15. Neurogene
32. Global Neurogenomics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Neurogenomics Market
34. Recent Developments In The Neurogenomics Market
35. Neurogenomics Market High Potential Countries, Segments and Strategies
35.1 Neurogenomics Market In 2029 - Countries Offering Most New Opportunities
35.2 Neurogenomics Market In 2029 - Segments Offering Most New Opportunities
35.3 Neurogenomics Market In 2029 - Growth Strategies
